Vigorous IV Hydration Regimen Cuts Post-ERCP Pancreatitis Risk

Share this content:
Vigorous IV Hydration Regimen Cuts Post-ERCP Pancreatitis Risk
Vigorous IV Hydration Regimen Cuts Post-ERCP Pancreatitis Risk

THURSDAY, Dec. 22, 2016 (HealthDay News) -- Vigorous periprocedural intravenous fluid resuscitation (IVFR) with lactated Ringer's solution can reduce the incidence and severity of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in average-risk and high-risk cases, according to a study published in the January issue of Clinical Gastroenterology and Hepatology.

Jun-Ho Choi, M.D., from Dankook University College of Medicine in Cheonan, Korea, and colleagues randomly assigned 510 patients (1:1) to either vigorous IVFR (lactated Ringer's solution in an initial bolus of 10 mL/kg before the procedure, 3 mL/kg/h during the procedure and for eight hours after the procedure, and a post-procedure bolus of 10 mL/kg) or a standard IVFR (lactated Ringer's solution at 1.5 mL/kg/h during and for eight hours after the procedure).

The researchers found that the main indications for ERCP were choledocholithiasis (58 percent) and malignant biliary stricture (27 percent). Post-ERCP pancreatitis developed in 11 patients in the vigorous IVFR group and 25 patients in the standard IVFR group (relative risk, 0.41; P = 0.016). In the vigorous group, a significantly smaller proportion of patients developed moderate or severe acute pancreatitis versus the standard IVFR group (P = 0.040). One patient in the vigorous IVFR group developed peripheral edema.

"Additional confirmatory studies will be necessary to support our conclusions and to assess the optimal protocol and volume of IVFR," the authors write.

Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »